Understanding Hypermobile Ehlers-Danlos Syndrome, the Lymphatic System, and Systemic Regulation

Over the past year, I’ve seen a growing number of clients whose health histories initially appear unrelated on the surface -joint instability, chronic fatigue, migraines, endometriosis, gut disorders, low blood pressure, persistent inflammation - yet when viewed through a connective tissue lens, a coherent physiological pattern emerges. One of the most important and under-recognised conditions associated with this presentation is Hypermobile Ehlers-Danlos syndrome (hEDS).

It is not rare. It is not benign. And it is profoundly misunderstood.

Lets explore what hEDS is, how it affects the lymphatic and nervous systems, and why recognising it can fundamentally change how we approach healing.

What is Hypermobile Ehlers-Danlos Syndrome?

Hypermobile Ehlers-Danlos syndrome is a heritable connective tissue disorder characterised by joint hypermobility, tissue fragility, and widespread systemic involvement. Unlike other forms of Ehlers-Danlos syndromes, hEDS currently has no identified single genetic marker. Diagnosis is clinical, based on criteria established in the 2017 International Classification. At its core, hEDS is a disorder of collagen and extracellular matrix integrity. Collagen is not simply structural, but rather regulatory.

It forms the framework of:

• Blood vessels

• Lymphatic vessels

• Fascia

• Ligaments and tendons

• Gut lining

• Nervous system sheaths

• Pelvic organs

• Skin

When collagen behaves differently, every regulatory system built upon it is affected. Prevalence is far more common than previously believed. Older estimates suggested EDS affected 1 in 5,000 people. More recent data suggests hypermobility spectrum disorders and hEDS together may affect 1–3% of the population, with many remaining undiagnosed. Women are disproportionately affected and diagnosis delays average 10-20 years.

The Connective Tissue–Circulation–Lymphatic Axis

The lymphatic system is structurally dependent on connective tissue integrity. Unlike the cardiovascular system, the lymphatic system has no central pump. It relies on:

• Vessel wall tone

• Skeletal muscle contraction

• Respiratory pressure gradients

• Fascial tension

• Intrinsic contractility of lymphatic vessels

When connective tissue is more ‘elastic’, lymphatic vessels may become less efficient at transporting fluid. This can result in Interstitial fluid stagnation, increased inflammatory load, impaired immune surveillance and slower metabolic waste clearance. Research demonstrates that lymphatic vessels rely on collagen and elastin fibres for structural support and optimal contractility (Rockson, 2001; Mortimer & Rockson, 2014). This has profound implications for systemic inflammation and immune regulation.

The Autonomic Nervous System, Immune System, and Fluid Regulation in hEDS

One of the most significant and well-documented associations with Hypermobile Ehlers-Danlos syndrome (hEDS) is dysfunction of the autonomic nervous system, particularly Postural Orthostatic Tachycardia Syndrome (POTS) and related dysautonomias.

The autonomic nervous system is responsible for regulating many of the body’s most fundamental survival processes, including blood pressure, heart rate, digestion, temperature regulation, immune signalling, and cerebral perfusion (which is all about pressure). These processes occur automatically, without conscious control, and are essential for maintaining physiological stability. Autonomic = Automatic.

Research suggests that up to 80% of individuals with hEDS exhibit some form of autonomic dysfunction (Hakim et al., 2017). This relationship is largely mechanical in origin. Blood vessels themselves are composed of connective tissue, and when connective tissue is more ‘slack’ than typical, the vessels may not constrict efficiently. This can lead to venous pooling, reduced return of blood to the heart and brain, reduced cerebral pressure, and the constellation of symptoms commonly reported is fatigue, dizziness, headaches, exercise intolerance, and orthostatic intolerance.

This is not psychological. It is structural, vascular, and neurological.

Closely related to this is the growing recognition of overlap between hEDS and Mast Cell Activation Syndrome (MCAS), a condition involving dysregulation of mast cells, which are immune cells embedded throughout connective tissue. Mast cells play an essential role in regulating inflammation, vascular permeability, immune defence, and tissue repair. When dysregulated, they can release inflammatory mediators inappropriately, contributing to skin inflammation, gastrointestinal dysfunction, fatigue, headaches, nervous system sensitisation, and hormonal disruption. Because mast cells reside within connective tissue matrices, alterations in connective tissue structure may influence mast cell stability and behaviour. This relationship is now recognised as an important area of ongoing research in connective tissue medicine.

Hormonal and pelvic implications are also significant. There is a well-established association between hEDS and conditions such as Endometriosis, PCOS (Polycystic ovary syndrome), pelvic organ prolapse, and chronic pelvic pain. Connective tissue provides structural support to pelvic organs and also plays a critical role in lymphatic drainage and inflammatory clearance. When connective tissue integrity is altered, lymphatic transport efficiency may be reduced, potentially contributing to persistence of inflammatory mediators within pelvic tissues.

The neurological implications extend even further, involving the glymphatic system- the brain’s specialised waste clearance pathway. The glymphatic system relies on perivascular spaces, astroglial aquaporin-4 water channels, and pressure gradients generated through respiration and vascular pulsation to clear metabolic waste from the central nervous system. When fluid regulation and vascular dynamics are altered, glymphatic clearance efficiency may be affected. This may contribute to neurological symptoms frequently reported in individuals with hEDS, including migraines, cognitive fatigue, and brain fog.

Understanding these mechanisms fundamentally changes how treatment should be approached. Individuals with connective tissue disorders often do not respond optimally to force-based, aggressive interventions. Their physiology responds more effectively to approaches that support regulation rather than force correction. This includes interventions that support lymphatic transport, autonomic nervous system regulation, circulatory efficiency, and inflammatory clearance.

Manual lymphatic drainage is particularly relevant in this population. The lymphatic system is responsible for immune surveillance, inflammatory clearance, and maintenance of fluid homeostasis. Research has demonstrated that MLD (manual lymphatic drainage) can influence autonomic nervous system activity, promoting parasympathetic dominance and improving physiological regulation (Shim et al., 2014). In individuals with autonomic dysregulation, connective tissue differences, and impaired fluid dynamics, supporting lymphatic transport may play an important role in reducing systemic load and improving overall regulation.

Diagnosis of hEDS remains clinical and is based on joint hypermobility assessment, medical history, and systemic features, as outlined by the The Ehlers-Danlos Society. Increasing awareness among clinicians is improving recognition, but many individuals remain undiagnosed for years.

What is becoming increasingly clear is that hEDS is not simply a condition of joint hypermobility. It is a systems-level condition involving connective tissue integrity, vascular function, lymphatic transport, immune regulation, and nervous system stability. Recognising this broader physiological context allows for more appropriate, supportive, and effective treatment strategies.

Many individuals spend years treating isolated symptoms without realising they are expressions of the same underlying connective tissue framework. When that framework is understood, the clinical approach shifts - from symptom management to systemic support, regulation, and restoration of physiological flow.